Drug
Chf5259 OR Placebo Administration
Chf5259 OR Placebo Administration: highest development phase Phase 2, developed by Chiesi Farmaceutici. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Chiesi Farmaceutici
Trials
| Drug | Phase | Indication |
|---|---|---|
| CHF5259 or Placebo administration NCT02680197 | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) |
Latest
No recent events.
Follow Chf5259 OR Placebo Administration on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.